To assess whether the anti-cancer effect of SESN2 on endometrial cancer cells is regulated via the mTORC1 pathway, we treated SESN2 knocked-down HEC-1A and Ishikawa cells with rapamycin and Torin 1. This evidence concerns the gene SESN2 and endometrial cancer.